Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
02 11월 2024 - 6:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
| | |
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ |
Check the appropriate box:
| | | | | |
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
| | |
| Salarius Pharmaceuticals, Inc. |
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| | | | | | | | |
☒ | No fee required. |
| | | |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| | (1) | Amount Previously Paid: |
| | | |
| | (2) | Form, Schedule or Registration Statement No.: |
| | | |
| | (3) | Filing Party: |
| | | |
| | (4) | Date Filed: |
| | | |
Salarius Pharmaceuticals (NASDAQ:SLRX)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Salarius Pharmaceuticals (NASDAQ:SLRX)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025
